Status:
COMPLETED
Pharmacokinetics Ertapenem Burns
Lead Sponsor:
Nantes University Hospital
Conditions:
Burn Patients
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
This study will examine the pharmacokinetics of ertapenem in ventilated badly (\> 30% SCT) burn patients.
Eligibility Criteria
Inclusion
- Patients aged 18 to 70 years
- Burned on 30 to 60% of their body surface
- Mechanical ventilation
- Hospitalized in the intensive care unit of Nantes University Hospital for less than 8 days.
- Which the family gave consent
- insured
Exclusion
- Patients whose family refused to sign the consent for participation.
- Patients allergic to beta lactam
- Patients with renal failure with creatinine clearance \<80 ml.mn-1
- Pregnant women
- Persons protected by the law
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT01497990
Start Date
January 1 2010
End Date
September 1 2011
Last Update
November 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantes University Hospital
Nantes, France, 44000